The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways
Acute respiratory distress syndrome (ARDS) is defined as a type of respiratory failure that is caused by a variety of insults such as pneumonia, sepsis, trauma and certain viral infections. In this study, we investigated the effect of an endocannabinoid, anandamide (AEA), on ARDS induced in the mous...
Saved in:
Main Authors: | Muthanna Sultan (Author), Hasan Alghetaa (Author), Amirah Mohammed (Author), Osama A. Abdulla (Author), Paul J. Wisniewski (Author), Narendra Singh (Author), Prakash Nagarkatti (Author), Mitzi Nagarkatti (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Administration of Δ9‐Tetrahydrocannabinol (THC) Post‐Staphylococcal Enterotoxin B Exposure Protects Mice From Acute Respiratory Distress Syndrome and Toxicity
by: Amira Mohammed, et al.
Published: (2020) -
Resveratrol attenuates staphylococcal enterotoxin B-activated immune cell metabolism via upregulation of miR-100 and suppression of mTOR signaling pathway
by: Hasan Alghetaa, et al.
Published: (2023) -
Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
by: Prakash Nagarkatti, et al.
Published: (2020) -
Editorial: Substance abuse and the microbiome
by: Prakash Nagarkatti, et al.
Published: (2024) -
Tryptamine Attenuates Experimental Multiple Sclerosis Through Activation of Aryl Hydrocarbon Receptor
by: Nicholas Dopkins, et al.
Published: (2021)